Yifan Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Yifan Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Yifan Pharmaceutical Co Ltd Strategy Report
- Understand Yifan Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Yifan Pharmaceutical Co Ltd (Yifan) develops, manufactures, markets active pharmaceutical ingredients, medical products and polymer materials. The company’s products include Chinese traditional medicines, women’s health medicines, hematologic maliganancies, inflammatory, endocrinology/metabolic, dermatological, gynecologic and pediatric diseases and among others. The company develops products based on its proprietary DiKine dimeric cytokine platform and iTab immune therapy antibody platform. Its pipeline products are targeted for the treatment of neutropenia, alcoholic hepatitis, acute pancreatitis, solid tumors, B-cell leukaemia, and others. Yifan is headquartered in Hangzhou, Zhejiang, China.
Headquarters
China
Address
No. 50, Qinshan, Jincheng Street, Linan City, Hangzhou, Zhejiang, 311300
Website
www.yifanyy.com
Telephone
86 551 62672019
No of Employees
4,338
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
002019 (SHE)
Revenue (2021)
$570.2M
-13%
(2021 vs 2020)
EPS
XYZ
Net Income (2021)
XYZ
-31.3%
(2021 vs 2020)
Market Cap*
$2.2B
Net Profit Margin (2021)
XYZ
-20.9%
(2021 vs 2020)
* As of and is in US$
Yifan Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Medicines: | iTab |
| Traditional Chinese Medicine | DiKine |
| Women’s Health | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Yifan Pharmaceutical Co Ltd | China National Accord Medicines Corporation Ltd | CSPC Pharmaceutical Group Ltd | Sino Biopharmaceutical Ltd | DSM Nutritional Products AG |
|---|---|---|---|---|---|
| Headquarters | China | China | China | Hong Kong | Switzerland |
| City | Hangzhou | Shenzhen | Shijiazhuang | Hong Kong | Basel |
| State/Province | Zhejiang | Guangdong | Hebei | - | Aargau |
| No. of Employees | 4,338 | 39,449 | 23,500 | 25,806 | 3,300 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Cheng Xianfeng | Chairman; President | Executive Board | 2019 | 54 |
| Feng Deqi | Director; Secretary; Vice President | Executive Board | 2019 | 43 |
| Hang Lin | Vice President; Director | Executive Board | - | 36 |
| Yu Haixia | Chief Financial Officer | Senior Management | 2012 | 44 |
| Yuhong Geng | Vice President | Senior Management | - | 52 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer